{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[14,2,14,3],[15,2,15,3],[19,2,19,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910450385403321"]
[null,null,"Titolo",null,"Novel targets in breast disease [[electronic resource] /] / edited by Stan Lipkowitz"]
[null,null,"Pubbl/distr/stampa",null,"Amsterdam ; ; Washington, DC, : IOS Press, c2003"]
[null,null,"ISBN",null,"1-280-50593-1"]
[{"$nulls":4},"9786610505937"]
[{"$nulls":4},"1-4175-1152-4"]
[{"$nulls":4},"600-00-0505-9"]
[{"$nulls":4},"1-60129-449-2"]
[null,null,"Descrizione fisica",null,"1 online resource (97 p.)"]
[null,null,"Disciplina",null,"616.99/44906"]
[null,null,"Soggetti",null,"Breast - Diseases"]
[{"$nulls":4},"Breast - Cancer"]
[{"$nulls":4},"Breast - Cancer - Treatment"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"This is the book ed. of the journal Breast disease, vol. 15 (2002), issn 0888-6008\"--T.p. verso."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Cover; Title page; Contents; Introduction; Targeting the estrogen receptor in clinical breast cancer; HER-2/Neu signaling and therapeutic approaches in breast cancer; Farnesyltransferase inhibitors: Potential therapeutic for inflammatory breast cancer?; Role of cell cycle control and cyclin-dependent kinases in breast cancer; Heat shock protein 90 is a rational molecular target in breast cancer; The proteasome as a novel target for the treatment of breast cancer; Apoptosis and the treatment of breast cancer; Immunologic targets for breast cancer"]
[null,null,null,"Sommario/riassunto","This work is devoted to therapies that take advantage of molecular targets relevant to breast cancer - so called novel molecular therapies. It presents a sampling of both old and new molecularly targeted therapies that are being developed."]